Company news
SK bioscience Co.,Ltd. news in 2025
SK bioscience Co.,Ltd.'s news releases, calls and decks from 2025, newest first.
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
October 15, 2025
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift
September 2, 2025
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health
August 21, 2025
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate
July 17, 2025
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
May 21, 2025
IDT Biologika Accelerates Global Growth Through Strategic CDMO Partnership
May 20, 2025
SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats
May 6, 2025
SK bioscience Expands Influenza Vaccine Exports to Southern Hemisphere Market
March 12, 2025
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
February 25, 2025